(Q34189137)

31 July 2017

1 reference

title

Conjugates and reverse vaccinology to eliminate bacterial meningitis (English)

1 reference

31 July 2017

1 reference

1

Rappuoli R

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

31 July 2017

1 reference

31 July 2017

volume

19

1 reference

31 July 2017

issue

17-19

1 reference

31 July 2017

page(s)

2319-2322

1 reference

Bacterial meningitis in the United States in 1995. Active Surveillance Team

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900552-1

7 January 2021

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900552-1

7 January 2021

Efficacy of pneumococcal conjugate vaccines in large scale field trials

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900552-1

7 January 2021

Development and phase 1 clinical testing of a conjugate vaccine against meningococcus A and C

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900552-1

7 January 2021

Safety and immunogenicity of meningococcal A and C polysaccharide conjugate vaccine in adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900552-1

7 January 2021

A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900552-1

7 January 2021

Conjugate meningococcal serogroup A and C vaccine: reactogenicity and immunogenicity in United Kingdom infants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900552-1

7 January 2021

Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900552-1

7 January 2021

Induction of immunological memory in UK infants by a meningococcal A/C conjugate vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900552-1

7 January 2021

Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900552-1

7 January 2021

Antibodies to polysialic acid and its N-propyl derivative: binding properties and interaction with human embryonal brain glycopeptides

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900552-1

7 January 2021

Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900552-1

7 January 2021

Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900552-1

7 January 2021

Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile. Chilean National Committee for Meningococcal Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900552-1

7 January 2021

Granuloma-specific expression of Mycobacterium virulence proteins from the glycine-rich PE-PGRS family

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900552-1

7 January 2021

Complete Genome Sequence of Neisseria meningitidis Serogroup B Strain MC58

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900552-1

7 January 2021

Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900552-1

7 January 2021

10.1016/S0264-410X(00)00552-1

Identifiers

DOI

1 reference

31 July 2017

1 reference